Qube Research & Technologies (QRT)
INBX icon

Qube Research & Technologies (QRT)’s Inhibrx INBX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,886
Closed -$284K – 3769
2025
Q2 		$284K Sell
19,886
-28,021
-58% -$362K ﹤0.01% 2832
2025
Q1 		$670K Sell
47,907
-43,314
-47% -$588K ﹤0.01% 2428
2024
Q4 		$1.4M Sell
91,221
-18,720
-17% -$285K ﹤0.01% 2028
2024
Q3 		$1.72M Sell
109,941
-31,459
-22% -$442K ﹤0.01% 1813
2024
Q2 		$2M Buy
+141,400
New +$2.21M ﹤0.01% 1621

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INBX Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Inhibrx (INBX) in Q3 2025, closing a stake of 19,886 shares — an estimated $284K sold.

Qube Research & Technologies (QRT) first reported a position in INBX in Q2 2024 and held it in 5 quarters. The position peaked at $2M in Q2 2024. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Inhibrx position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 19,886 Inhibrx shares in Q3 2025, an estimated $284K.
  • Qube Research & Technologies (QRT) first reported a position in Inhibrx in Q2 2024 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Inhibrx position peaked at $2M in Q2 2024.
  • 102 funds tracked by Wall St. Rank held Inhibrx as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.